Dermatologie Maldegem

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Psoriasis1 trial

Phase

• Phase 32 trials
• Phase 41 trial

Status

• Completed3 trials

Lead sponsor

• Amgen2 trials
• Radboud University Medical Center1 trial

Closed trials

• Completed

  A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05704738· Phase 3· Amgen· Source

• Completed

  A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

  NCT05651711· Phase 3· Amgen· Source

• Completed

  Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

  NCT04340076· Phase 4· Radboud University Medical Center· Source